192 related articles for article (PubMed ID: 33737384)
1. Identification and characterization of conserved noncoding
Shao Y; Bajikar SS; Tirumala HP; Gutierrez MC; Wythe JD; Zoghbi HY
Genes Dev; 2021 Apr; 35(7-8):489-494. PubMed ID: 33737384
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
[TBL] [Abstract][Full Text] [Related]
3. Role of conserved cis-regulatory elements in the post-transcriptional regulation of the human MECP2 gene involved in autism.
Bagga JS; D'Antonio LA
Hum Genomics; 2013 Sep; 7(1):19. PubMed ID: 24040966
[TBL] [Abstract][Full Text] [Related]
4. Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice.
Heckman LD; Chahrour MH; Zoghbi HY
Elife; 2014 Jun; 3():. PubMed ID: 24970834
[TBL] [Abstract][Full Text] [Related]
5. Identification of molecular signatures and pathways involved in Rett syndrome using a multi-omics approach.
Pascual-Alonso A; Xiol C; Smirnov D; Kopajtich R; Prokisch H; Armstrong J
Hum Genomics; 2023 Sep; 17(1):85. PubMed ID: 37710353
[TBL] [Abstract][Full Text] [Related]
6. Exploration of group II metabotropic glutamate receptor modulation in mouse models of Rett syndrome and MECP2 Duplication syndrome.
Vermudez SAD; Buch A; Weiss K; Gogliotti RG; Niswender CM
Neuropharmacology; 2022 May; 209():109022. PubMed ID: 35248529
[TBL] [Abstract][Full Text] [Related]
7. MECP2 mutations and clinical correlations in Greek children with Rett syndrome and associated neurodevelopmental disorders.
Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
Brain Dev; 2012 Jun; 34(6):487-95. PubMed ID: 21982064
[TBL] [Abstract][Full Text] [Related]
8. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
9. RNA sequencing and proteomics approaches reveal novel deficits in the cortex of
Pacheco NL; Heaven MR; Holt LM; Crossman DK; Boggio KJ; Shaffer SA; Flint DL; Olsen ML
Mol Autism; 2017; 8():56. PubMed ID: 29090078
[TBL] [Abstract][Full Text] [Related]
10. Identification of cis-regulatory elements for MECP2 expression.
Liu J; Francke U
Hum Mol Genet; 2006 Jun; 15(11):1769-82. PubMed ID: 16613900
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
Chen RZ; Akbarian S; Tudor M; Jaenisch R
Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
[TBL] [Abstract][Full Text] [Related]
12. The molecular pathology of Rett syndrome: synopsis and update.
Akbarian S; Jiang Y; Laforet G
Neuromolecular Med; 2006; 8(4):485-94. PubMed ID: 17028371
[TBL] [Abstract][Full Text] [Related]
13. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.
Chang Q; Khare G; Dani V; Nelson S; Jaenisch R
Neuron; 2006 Feb; 49(3):341-8. PubMed ID: 16446138
[TBL] [Abstract][Full Text] [Related]
14. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
15. Advances in understanding of Rett syndrome and MECP2 duplication syndrome: prospects for future therapies.
Sandweiss AJ; Brandt VL; Zoghbi HY
Lancet Neurol; 2020 Aug; 19(8):689-698. PubMed ID: 32702338
[TBL] [Abstract][Full Text] [Related]
16. MECP2 disorders: from the clinic to mice and back.
Lombardi LM; Baker SA; Zoghbi HY
J Clin Invest; 2015 Aug; 125(8):2914-23. PubMed ID: 26237041
[TBL] [Abstract][Full Text] [Related]
17. A rare MeCP2_e1 mutation first described in a male patient with severe neonatal encephalopathy.
Soffer OD; Sidlow R
Am J Med Genet A; 2016 Jul; 170(7):1881-3. PubMed ID: 27090848
[TBL] [Abstract][Full Text] [Related]
18. MECP2 Duplication Syndrome: Evidence of Enhanced Oxidative Stress. A Comparison with Rett Syndrome.
Signorini C; De Felice C; Leoncini S; Møller RS; Zollo G; Buoni S; Cortelazzo A; Guerranti R; Durand T; Ciccoli L; D'Esposito M; Ravn K; Hayek J
PLoS One; 2016; 11(3):e0150101. PubMed ID: 26930212
[TBL] [Abstract][Full Text] [Related]
19. A brief history of MECP2 duplication syndrome: 20-years of clinical understanding.
Ta D; Downs J; Baynam G; Wilson A; Richmond P; Leonard H
Orphanet J Rare Dis; 2022 Mar; 17(1):131. PubMed ID: 35313898
[TBL] [Abstract][Full Text] [Related]
20. ATRX Contributes to MeCP2-Mediated Pericentric Heterochromatin Organization during Neural Differentiation.
Marano D; Fioriniello S; Fiorillo F; Gibbons RJ; D'Esposito M; Della Ragione F
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
